Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2016-03-31, filed 2016-05-27, with 24 holding rows worth $477,375,000.

Accession
0001475373-16-000004
Filed
2016-05-27
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2016

A holdings report, 24 entries on the cover page, a total value of $477,375,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $477,375,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Eli Lilly and Company532457108COM771,390$55,548,000thousands by filing date
BAXTER INTL INC071813109COM1,217,830$50,028,000thousands by filing date
Boston Scientific Corporation101137107COM1,766,250$33,223,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK2,486,757$27,205,000thousands by filing date
ST JUDE MED INC790849103COM473,514$26,043,000thousands by filing date
REVVITY INC714046109COM499,030$24,682,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO135,680$23,323,000thousands by filing date
Merck & Co.,Inc.58933Y105COM434,160$22,971,000thousands by filing date
BIOGEN INC COM09062X103Stock81,910$21,323,000thousands by filing date
Bristol-Myers Squibb Company110122108COM328,740$21,000,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW301,457$20,306,000thousands by filing date
BIO RAD LABS INC090572207CL A132,764$18,151,000thousands by filing date
MEDIVATION INC58501N101COM385,923$17,745,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM208,243$16,553,000thousands by filing date
PATTERSON COS INC703395103COM331,264$15,414,000thousands by filing date
BAXALTA INC07177M103COM356,310$14,395,000thousands by filing date
MCKESSON CORP COM58155Q103Stock88,640$13,939,000thousands by filing date
CIGNA CORPORATION125509109COM99,610$13,670,000thousands by filing date
MASIMO CORP COM574795100Stock318,463$13,324,000thousands by filing date
ACCENDRA HEALTH INC690732102COM221,252$8,943,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM780,313$7,210,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock60,204$6,709,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock178,490$5,164,000thousands by filing date
SPECTRUM PHARMACEUTICALS INC84763A108COM79,600$506,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001475373-16-000004this filing2016-05-27acceptance time not in the bulk data set
13F-HR/A 0001475373-17-000003 added2017-03-03acceptance time not in the bulk data set